Trials / Terminated
TerminatedNCT00419120
Augmentation Cystoplasty Using an Autologous Neo-Bladder
An Open-Label Multicenter Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct in Subjects With Spina Bifida
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Tengion · Industry
- Sex
- All
- Age
- 3 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
Subjects with neurogenic bladder secondary to spina bifida refractory to medical treatment will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will significantly increase bladder compliance.
Detailed description
Subjects with neurogenic bladder secondary to spina bifida (myelodysplasia) that is refractory to medical treatment and require augmentation cystoplasty will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will significantly increase bladder compliance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous neo bladder construct | augmentation cystoplasty with autologous neo-bladder construct |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2008-10-01
- Completion
- 2011-04-01
- First posted
- 2007-01-08
- Last updated
- 2015-11-30
- Results posted
- 2010-06-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00419120. Inclusion in this directory is not an endorsement.